Search Results | Clinical Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop

Clin Cancer Res (2021) 27 (20): 5472–5481.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1799

Published: 15 October 2021

View article

Includes: Supplementary data

Journal Articles

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group

Allison Magnuson, Suanna S. Bruinooge, Harpreet Singh, Keith D. Wilner, Shadia Jalal, Stuart M. Lichtman, Paul G. Kluetz, Gary H. Lyman, Heidi D. Klepin, Mark E. Fleury, Brad Hirsch, Allen Melemed, Fernanda I. Arnaldez, Upal Basu Roy, Caroline Schenkel, Shimere Sherwood, Elizabeth Garrett-Mayer

Clin Cancer Res (2021) 27 (9): 2424–2429.

DOI: https://doi.org/10.1158/1078-0432.CCR-20-3868

Published: 01 May 2021

View article

Journal Articles

Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations

R. Donald Harvey, Suanna S. Bruinooge, Li Chen, Elizabeth Garrett-Mayer, Whitney Rhodes, Edward Stepanski, Thomas S. Uldrick, Gwynn Ison, Sean Khozin, Wendy S. Rubinstein, Caroline Schenkel, Robert S. Miller, George A. Komatsoulis, Richard L. Schilsky, Edward S. Kim

Clin Cancer Res (2021) 27 (9): 2430–2434.

DOI: https://doi.org/10.1158/1078-0432.CCR-20-3857

Published: 01 May 2021

View article

Includes: Supplementary data

Journal Articles

Abstract PO-022: Impact of COVID-19 pandemic on new patient and consult visits at 20 hematology/oncology practices in the ASCO PracticeNET learning network

Brian Bourbeau, Mou Guharoy, Elizabeth Garrett-Mayer, Stephen Grubbs, Paul Unger, Barbara McAneny, Richard L. Schilsky

Clin Cancer Res (2020) 26 (18_Supplement): PO-022.

DOI: https://doi.org/10.1158/1557-3265.COVID-19-PO-022

Published: 15 September 2020

View article

Journal Articles

Abstract S06-01: Changes implemented by U.S. oncology practices in response to COVID-19 pandemic: Initial report from the ASCO Registry on COVID-19 and cancer

Suanna S. Bruinooge, Elizabeth Garrett-Mayer, Stephen Meersman, Patricia Hurley, Brian Bourbeau, Allyn Moushey, Sybil Green, Deborah Kamin, Stephen Grubbs, Richard L. Schilsky

Clin Cancer Res (2020) 26 (18_Supplement): S06-01.

DOI: https://doi.org/10.1158/1557-3265.COVID-19-S06-01

Published: 15 September 2020

View article

Journal Articles

Abstract PO-015: Differences in level-of-service for telehealth visits as compared to in-office visits for cancer and hematology patients seen in practices within the ASCO PracticeNET learning network

Brian Bourbeau, Mou Guharoy, Stephen Grubbs, Elizabeth Garrett-Mayer, Kevin Olson, Richard L. Schilsky

Clin Cancer Res (2020) 26 (18_Supplement): PO-015.

DOI: https://doi.org/10.1158/1557-3265.COVID-19-PO-015

Published: 15 September 2020

View article

Journal Articles

Development and Validation of a Prognostic Model for Patients with Advanced Lung Cancer Treated with the Immune Checkpoint Inhibitor Atezolizumab

Ashley M. Hopkins, Ganessan Kichenadasse, Elizabeth Garrett-Mayer, Christos S. Karapetis, Andrew Rowland, Michael J. Sorich

Clin Cancer Res (2020) 26 (13): 3280–3286.

DOI: https://doi.org/10.1158/1078-0432.CCR-19-2968

Published: 01 July 2020

View article

Includes: Supplementary data

Journal Articles

A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors

Carolyn D. Britten, Elizabeth Garrett-Mayer, Steven H. Chin, Keisuke Shirai, Besim Ogretmen, Tricia A. Bentz, Alan Brisendine, Kate Anderton, Susan L. Cusack, Lynn W. Maines, Yan Zhuang, Charles D. Smith, Melanie B. Thomas

Clin Cancer Res (2017) 23 (16): 4642–4650.

DOI: https://doi.org/10.1158/1078-0432.CCR-16-2363

Published: 14 August 2017

View article

Journal Articles

Results of a Phase II Trial of Gemcitabine Plus Doxorubicin in Patients with Recurrent Head and Neck Cancers: Serum C₁₈-Ceramide as a Novel Biomarker for Monitoring Response

Sahar A. Saddoughi, Elizabeth Garrett-Mayer, Uzair Chaudhary, Paul E. O'Brien, Larry B. Afrin, Terry A. Day, M. Boyd Gillespie, Anand K. Sharma, Christina S. Wilhoit, Robin Bostick, Can E. Senkal, Yusuf A. Hannun, Jacek Bielawski, George R. Simon, Keisuke Shirai, Besim Ogretmen

Clin Cancer Res (2011) 17 (18): 6097–6105.

DOI: https://doi.org/10.1158/1078-0432.CCR-11-0930

Published: 14 September 2011

View article

Journal Articles

Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

S. Percy Ivy, Lillian L. Siu, Elizabeth Garrett-Mayer, Larry Rubinstein

Clin Cancer Res (2010) 16 (6): 1726–1736.

DOI: https://doi.org/10.1158/1078-0432.CCR-09-1961

Published: 14 March 2010

View article

Journal Articles

Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer

Andrew J. Armstrong, Elizabeth Garrett-Mayer, Ronald de Wit, Ian Tannock, Mario Eisenberger

Clin Cancer Res (2010) 16 (1): 203–211.

DOI: https://doi.org/10.1158/1078-0432.CCR-09-2514

Published: 04 January 2010

View article

Includes: Supplementary data

Journal Articles

K562/GM-CSF Immunotherapy Reduces Tumor Burden in Chronic Myeloid Leukemia Patients with Residual Disease on Imatinib Mesylate

B. Douglas Smith, Yvette L. Kasamon, Jeanne Kowalski, Christopher Gocke, Kathleen Murphy, Carole B. Miller, Elizabeth Garrett-Mayer, Hua-Ling Tsai, Lu Qin, Christina Chia, Barbara Biedrzycki, Thomas C. Harding, Guang Haun Tu, Richard Jones, Kristen Hege, Hyam I. Levitsky

Clin Cancer Res (2010) 16 (1): 338–347.

DOI: https://doi.org/10.1158/1078-0432.CCR-09-2046

Published: 04 January 2010

View article

Includes: Supplementary data

Journal Articles

Phase II Trial of Tipifarnib as Maintenance Therapy in First Complete Remission in Adults with Acute Myelogenous Leukemia and Poor-Risk Features

Judith E. Karp, B. Douglas Smith, Ivana Gojo, Jeffrey E. Lancet, Jacqueline Greer, Maureen Klein, Larry Morris, Mark J. Levis, Steven D. Gore, John J. Wright, Elizabeth Garrett-Mayer

Clin Cancer Res (2008) 14 (10): 3077–3082.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-4743

Published: 15 May 2008

View article

Journal Articles

Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma

Clin Cancer Res (2008) 14 (1): 97–107.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-0722

Published: 02 January 2008

View article

Includes: Supplementary data

Journal Articles

Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid

Mary Jo Fackler, Kara Malone, Zhe Zhang, Eric Schilling, Elizabeth Garrett-Mayer, Theresa Swift-Scanlan, Julie Lange, Ritu Nayar, Nancy E. Davidson, Seema A. Khan, Saraswati Sukumar

Clin Cancer Res (2006) 12 (11): 3306–3310.

DOI: https://doi.org/10.1158/1078-0432.CCR-05-2733

Published: 01 June 2006

View article

Journal Articles

Phase I Study of Low-Dose Interleukin-2, Fludarabine, and Cyclophosphamide for Previously Untreated Indolent Lymphoma and Chronic Lymphocytic Leukemia

Yvette L. Kasamon, Ian W. Flinn, Michael R. Grever, Louis F. Diehl, Elizabeth Garrett-Mayer, Steven N. Goodman, Margaret S. Lucas, John C. Byrd

Clin Cancer Res (2005) 11 (23): 8413–8417.

DOI: https://doi.org/10.1158/1078-0432.CCR-05-1612

Published: 01 December 2005

View article

Journal Articles

Very High Frequency of Hypermethylated Genes in Breast Cancer Metastasis to the Bone, Brain, and Lung

Jyoti Mehrotra, Mustafa Vali, Megan McVeigh, Scott L. Kominsky, Mary Jo Fackler, Jaana Lahti-Domenici, Kornelia Polyak, Nicoletta Sacchi, Elizabeth Garrett-Mayer, Pedram Argani, Saraswati Sukumar

Clin Cancer Res (2004) 10 (9): 3104–3109.

DOI: https://doi.org/10.1158/1078-0432.CCR-03-0118

Published: 06 May 2004

View article

NARROW

A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group

Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations

Abstract PO-022: Impact of COVID-19 pandemic on new patient and consult visits at 20 hematology/oncology practices in the ASCO PracticeNET learning network

Abstract S06-01: Changes implemented by U.S. oncology practices in response to COVID-19 pandemic: Initial report from the ASCO Registry on COVID-19 and cancer

Abstract PO-015: Differences in level-of-service for telehealth visits as compared to in-office visits for cancer and hematology patients seen in practices within the ASCO PracticeNET learning network

Development and Validation of a Prognostic Model for Patients with Advanced Lung Cancer Treated with the Immune Checkpoint Inhibitor Atezolizumab

A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors

Results of a Phase II Trial of Gemcitabine Plus Doxorubicin in Patients with Recurrent Head and Neck Cancers: Serum C₁₈-Ceramide as a Novel Biomarker for Monitoring Response

Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer

K562/GM-CSF Immunotherapy Reduces Tumor Burden in Chronic Myeloid Leukemia Patients with Residual Disease on Imatinib Mesylate

Phase II Trial of Tipifarnib as Maintenance Therapy in First Complete Remission in Adults with Acute Myelogenous Leukemia and Poor-Risk Features

Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma

Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid

Phase I Study of Low-Dose Interleukin-2, Fludarabine, and Cyclophosphamide for Previously Untreated Indolent Lymphoma and Chronic Lymphocytic Leukemia

Very High Frequency of Hypermethylated Genes in Breast Cancer Metastasis to the Bone, Brain, and Lung

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only